Cancer and cancer-therapy related cognitive dysfunction: an international perspective from the Venice cognitive workshop.
about
Non-pharmacological interventions for cognitive impairment due to systemic cancer treatmentCancer- and cancer treatment-associated cognitive change: an update on the state of the scienceChemobrain: a critical review and causal hypothesis of link between cytokines and epigenetic reprogramming associated with chemotherapyPotential epigenetic mechanism(s) associated with the persistence of psychoneurological symptoms in women receiving chemotherapy for breast cancer: a hypothesisPostoperative Structural Brain Changes and Cognitive Dysfunction in Patients with Breast CancerWhat is known and unknown about chemotherapy-related cognitive impairment in patients with haematological malignancies and areas of needed research.Cognitive function in breast cancer survivors compared to healthy age- and education-matched women.Opening up the window into "chemobrain": a neuroimaging review3D surface analysis of hippocampal microvasculature in the irradiated brain.Chemotherapy and Cognitive Function in Breast Cancer Patients: The So-Called Chemo Brain.Verbal fluency in breast cancer patients treated with chemotherapy.Neuropsychological functioning and quality of life during the first year after completing chemotherapy for breast cancer.Testicular cancer survivorship: research strategies and recommendations.Cognitive function in postmenopausal women receiving adjuvant letrozole or tamoxifen for breast cancer in the BIG 1-98 randomized trial.A meta-analysis of cognitive impairment following adult cancer chemotherapy.Breast cancer morbidity: questionnaire survey of patients on the long term effects of disease and adjuvant therapyCardiac and cognitive effects of androgen deprivation therapy: are they real?Longitudinal assessment of cognitive changes associated with adjuvant treatment for breast cancer: impact of age and cognitive reserve.Memory loss during lenalidomide treatment: a report on two casesCaregiver-reported neuropsychiatric symptoms in patients undergoing treatment for head and neck cancer: a pilot studyProspective neurocognitive function over 5 years after allogeneic hematopoietic cell transplantation for cancer survivors compared with matched controls at 5 yearsCytokines as mediators of chemotherapy-associated cognitive changes: current evidence, limitations and directions for future researchConducting cancer control and survivorship research via cooperative groups: a report from the American Society of Preventive Oncology.Preserved learning and memory following 5-fluorouracil and cyclophosphamide treatment in ratsApolipoprotein E genotype and cognitive function in postmenopausal women with early-stage breast cancer.Long-term cognitive impairment in older adult twins discordant for gynecologic cancer treatmentSurvivorship: cognitive function, version 1.2014.Association of proinflammatory cytokines and chemotherapy-associated cognitive impairment in breast cancer patients: a multi-centered, prospective, cohort studyImpairment of cognitive function by chemotherapy: association with the disruption of phase-locking and synchronization in anterior cingulate cortexExamining the effects of adjuvant chemotherapy on cognition and the impact of any cognitive impairment on quality of life in colorectal cancer patients: study protocol.Alterations in brain activation during working memory processing associated with breast cancer and treatment: a prospective functional magnetic resonance imaging study.Changes of Brain Glucose Metabolism in the Pretreatment Patients with Non-Small Cell Lung Cancer: A Retrospective PET/CT Study.Central Nervous System Injury - A Newly Observed Bystander Effect of RadiationPAN-811 Blocks Chemotherapy Drug-Induced In Vitro Neurotoxicity, While Not Affecting Suppression of Cancer Cell GrowthReduced prefrontal activation during working and long-term memory tasks and impaired patient-reported cognition among cancer survivors postchemotherapy compared with healthy controls.Does tumor necrosis factor-alpha (TNF-α) play a role in post-chemotherapy cerebral dysfunction?Identification and prioritization of candidate genes for symptom variability in breast cancer survivors based on disease characteristics at the cellular level.Frontal gray matter reduction after breast cancer chemotherapy and association with executive symptoms: a replication and extension study.Polymorphisms in DNA repair and oxidative stress genes associated with pre-treatment cognitive function in breast cancer survivors: an exploratory studyGray matter reduction associated with systemic chemotherapy for breast cancer: a prospective MRI study.
P2860
Q26470426-E1FFC898-D747-4E90-829C-0F4686FB850EQ26853289-F9531EDC-2051-4254-AF03-3EE7FB7CD06CQ27011451-4CAAD929-2D5B-4806-916B-27BEE47328CAQ28393302-277EBEDC-9ED4-495E-BDA4-E18537789B2EQ28607865-73895A69-67D8-40DA-83DA-E7BA61B6E328Q30249112-C732F823-BD8A-461A-B5E2-430E4FF46EC1Q30458869-D04870A0-B6AF-4FB6-8F1C-435D16B277E6Q30596880-F0F214C2-C2B6-4619-BE56-E03646F60FB3Q30773573-AE43EC91-2240-4E0E-A0CA-95978EBB9BAEQ33360883-75013DE1-46AA-446C-BA12-1081DFE46BE9Q33575742-F8133D3E-1B1A-4CCD-831B-13444D64BECBQ33816589-B3ACED78-1659-4248-B088-5523F9E89444Q34039684-A8E864B8-8815-4B76-A1FF-1FC4B8D7173BQ34065038-86AFB4CE-0664-4AB9-9211-A1779883627DQ34083459-F1686572-5E3F-4A6A-87E2-C08892698230Q34106649-623232D2-8E74-4A56-868A-81E77484A478Q34111628-DBF6F53E-15E7-423A-8418-37FAD5D8E881Q34334920-E04FEECE-8CED-4B30-B048-BD541E8C0A31Q34929303-1B9E19A8-66BC-47DD-97D5-E61C827996ABQ35006844-E38C614D-5E75-4F19-8E9E-9FE569241FD2Q35023468-74FF728B-C6CD-4987-AF0C-CE453EEE3663Q35067446-5B9EDFBE-267B-48B3-BA06-CF1077FDA963Q35072010-9ABA9E2D-0618-4C9E-9373-672A91B18603Q35243657-4DA23981-8AEE-4030-A7FE-B6122B377FB4Q35523936-F9878DB1-B473-41C3-B619-684B72D95FA7Q35535907-3BC1128C-39B6-4D23-BFBF-29D9972AB823Q35734910-F83DEA6D-DBE5-4C70-9CD4-E05A2D1022B5Q35775258-6CB67A52-F37E-4871-9CD8-2383077128D3Q35814742-989AE88D-B9D3-4297-B668-152B061BD35AQ35854268-1886EFA1-E9E6-41BC-8329-F040207ADAF5Q36097701-49A8762E-97B5-40B8-962B-22D58C6FE3B4Q36104836-925BFDCA-FA01-4677-9B61-220327B85374Q36150038-F3FA1C5B-D551-4B3F-B0CD-CA901E2301DFQ36310404-0C08B0F8-9801-4D23-B638-44B1A75485EEQ36450200-67512485-9568-40A1-9BE1-206445EB688DQ36468050-ACA99C64-F50A-4554-AE4C-49963ECBFD37Q36684067-2110D21E-40EC-453B-970D-60A6AF267251Q36775693-0794F962-0421-43FB-A00E-C34710A44E59Q36783852-678EF791-76EA-4B81-93F3-E2F054A0DBCAQ36867082-3AFFADFD-1BED-46AB-8AAB-89250A143191
P2860
Cancer and cancer-therapy related cognitive dysfunction: an international perspective from the Venice cognitive workshop.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Cancer and cancer-therapy rela ...... the Venice cognitive workshop.
@en
Cancer and cancer-therapy rela ...... the Venice cognitive workshop.
@nl
type
label
Cancer and cancer-therapy rela ...... the Venice cognitive workshop.
@en
Cancer and cancer-therapy rela ...... the Venice cognitive workshop.
@nl
prefLabel
Cancer and cancer-therapy rela ...... the Venice cognitive workshop.
@en
Cancer and cancer-therapy rela ...... the Venice cognitive workshop.
@nl
P2093
P356
P1433
P1476
Cancer and cancer-therapy rela ...... the Venice cognitive workshop.
@en
P2093
P304
P356
10.1093/ANNONC/MDM500
P577
2007-10-31T00:00:00Z